Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tomoiki Aiba"'
Autor:
Soichiro Minami, Yosuke Kawashima, Yasuhiko Munakata, Masahiro Matsuno, Shuichiro Hara, Yusuke Yamazaki, Tsuyoshi Doman, Shin Saito, Tetsuo Odaka, Takahiro Ogasawara, Hisashi Shimizu, Jun Sugisaka, Tomoiki Aiba, Yukihiro Toi, Shinsuke Yamanda, Yuichiro Kimura, Shunichi Sugawara
Publikováno v:
Cancer Reports, Vol 7, Iss 7, Pp n/a-n/a (2024)
ABSTRACT Background The expansion of preoperative immunochemotherapy has led to an increase in the number of patients with lung cancer receiving immune checkpoint inhibitors (ICIs). Therefore, oncologists should manage a variety of immune‐related a
Externí odkaz:
https://doaj.org/article/5543c1d253ce41568754fb0610f4abf2
Autor:
Jun Sugisaka, Yukihiro Toi, Yosuke Kawashima, Yutaka Domeki, Tomoiki Aiba, Sachiko Kawana, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Shunichi Sugawara
Publikováno v:
Thoracic Cancer, Vol 14, Iss 31, Pp 3140-3146 (2023)
Abstract Background There is no well‐established late‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Therefore, we retrospectively determined the efficacy and safety of platinum rechallenge with paclitaxel‐carbopl
Externí odkaz:
https://doaj.org/article/84ab70da4dee413d96eac46f9b6875a9
Autor:
Yosuke Murakami, Yosuke Kawashima, Shinji Chiba, Shuichiro Hara, Yusuke Yamazaki, Tsuyoshi Doman, Shin Saito, Tetsuo Odaka, Takahiro Ogasawara, Hisashi Shimizu, Jun Sugisaka, Tomoiki Aiba, Yukihiro Toi, Shinsuke Yamanda, Yuichiro Kimura, Shunichi Sugawara
Publikováno v:
Cancer Reports, Vol 7, Iss 2, Pp n/a-n/a (2024)
Abstract Background Anaplastic lymphoma kinase (ALK)‐positive lung cancer has a better long‐term prognosis with ALK‐inhibitor than other lung cancers. However, resistance to ALK‐inhibitors and the control of metastases in the central nervous
Externí odkaz:
https://doaj.org/article/6a69036d500340d1912700c168116d18
Autor:
Susumu Takeuchi, Kaoru Kubota, Shunichi Sugawara, Satoshi Teramukai, Rintaro Noro, Kei Fujikawa, Takashi Hirose, Shinji Atagi, Seigo Minami, Shinichiro Iida, Hiroshi Kuraishi, Tomoiki Aiba, Yuji Minegishi, Masaru Matsumoto, Masahiro Seike, Akihiko Gemma, Masaaki Kawahara, Japan‐Multinational Trial Organization (JMTO)
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9133-9143 (2023)
Abstract Background Nab‐paclitaxel (nab‐PTX) has better transfer to tumor tissue than cremophor‐based paclitaxel. It suggests that the optimum dose of nab‐PTX might be lower than the dose and schedule that is widely used. We designed a random
Externí odkaz:
https://doaj.org/article/e54f4b393bff460b86372c2ec038f9a5
Autor:
Kana Ono, Hirotaka Ono, Yukihiro Toi, Jun Sugisaka, Mari Aso, Ryohei Saito, Sachiko Kawana, Tomoiki Aiba, Tetsuo Odaka, Suguru Matsuda, Shin Saito, Akane Narumi, Takahiro Ogasawara, Hisashi Shimizu, Yutaka Domeki, Keisuke Terayama, Yosuke Kawashima, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Yoshihiro Honda, Shunichi Sugawara
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4796-4804 (2021)
Abstract Background The association between the development of checkpoint inhibitor pneumonitis (CIP) with tumor response and survival has remained unclear so far. The aim of the present study was to evaluate the association between CIP and the clini
Externí odkaz:
https://doaj.org/article/efc9d6dd8dd248d5880341fb0395fe7c
Autor:
Tomoiki Aiba, Chieko Hattori, Jun Sugisaka, Hisashi Shimizu, Hirotaka Ono, Yutaka Domeki, Ryohei Saito, Sachiko Kawana, Yosuke Kawashima, Keisuke Terayama, Yukihiro Toi, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Yutaka Suzuki, Atsushi Niida, Shunichi Sugawara
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0260500 (2021)
Although anti-PD-1/PD-L1 monotherapy has achieved clinical success in non-small cell lung cancer (NSCLC), definitive predictive biomarkers remain to be elucidated. In this study, we performed whole-transcriptome sequencing of pretreatment tumor tissu
Externí odkaz:
https://doaj.org/article/ff8d011cd2ee41c8b003de2f9220edcd
Autor:
Mari Aso, Shunichi Sugawara, Sachiko Kawana, Tetsuo Odaka, Shinsuke Yamanda, Yukihiro Toi, Suguru Matsuda, Yoshihiro Honda, Hisashi Shimizu, Tomoiki Aiba, Ryohei Saito, Takahiro Ogasawara, Atsushi Nakamura, Akane Narumi, Hirotaka Ono, Yutaka Domeki, Keisuke Terayama, Shin Saito, Jun Sugisaka, Yosuke Kawashima, Kana Ono, Yuichiro Kimura
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4796-4804 (2021)
Cancer Medicine
Cancer Medicine
Background The association between the development of checkpoint inhibitor pneumonitis (CIP) with tumor response and survival has remained unclear so far. The aim of the present study was to evaluate the association between CIP and the clinical effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::522dcdcba25b5396c78e06db47c3741f
https://doaj.org/article/efc9d6dd8dd248d5880341fb0395fe7c
https://doaj.org/article/efc9d6dd8dd248d5880341fb0395fe7c
Autor:
Susumu Takeuchi, Kaoru Kubota, Shunichi Sugawara, Satoshi Teramukai, Rintaro Noro, Kei Fujikawa, Takashi Hirose, Shinji Atagi, Seigo Minami, Shinichiro Iida, Hiroshi Kuraishi, Tomoiki Aiba, Yuji Minegishi, Masaru Matsumoto, Masahiro Seike, Akihiko Gemma, Masaaki Kawahara
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e7164183f68dbe55d9fb302f31087d1
https://doi.org/10.2139/ssrn.4072907
https://doi.org/10.2139/ssrn.4072907
Autor:
Atsushi Nakamura, Shunichi Sugawara, Keisuke Terayama, Yukihiro Toi, Jun Sugisaka, Yutaka Domeki, Hisashi Shimizu, Ryohei Saito, Mari Aso, Kana Ono, Yoshihiro Honda, Sachiko Kawana, Yosuke Kawashima, Tomoiki Aiba, Shinsuke Yamanda, Takahiro Ogasawara, Kyoji Tsurumi, Yuichiro Kimura
Publikováno v:
The Oncologist. 25:e536-e544
Background Anti-programmed cell death 1 antibody is a standard therapy for advanced non-small cell lung cancer (NSCLC). However, immune-related adverse events (irAEs), such as skin reactions, are frequently observed. Although skin reactions are assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bdf1840107997318e09583347ae9a73
https://doi.org/10.1634/theoncologist.2019-0550
https://doi.org/10.1634/theoncologist.2019-0550
Autor:
Tomoiki Aiba, Ryohei Saito, Shunichi Sugawara, Yukihiro Toi, Sachiko Kawana, Atsushi Nakamura
Publikováno v:
Haigan. 59:60-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5716ac4e7d4b2a2307a97a9d53398df
https://doi.org/10.2482/haigan.59.60
https://doi.org/10.2482/haigan.59.60